Abstract
Background
The purpose of this study was to ascertain multimorbidity patterns using a non-hierarchical cluster analysis in adult primary patients with multimorbidity attended in primary care centers in Catalonia.
Methods
Cross-sectional study using electronic health records from 523,656 patients, aged 45–64 years in 274 primary health care teams in 2010 in Catalonia, Spain. Data were provided by the Information System for the Development of Research in Primary Care (SIDIAP), a population database. Diagnoses were extracted using 241 blocks of diseases (International Classification of Diseases, version 10). Multimorbidity patterns were identified using two steps: 1) multiple correspondence analysis and 2) k-means clustering. Analysis was stratified by sex.
Results
The 408,994 patients who met multimorbidity criteria were included in the analysis (mean age, 54.2 years [Standard deviation, SD: 5.8], 53.3% women). Six multimorbidity patterns were obtained for each sex; the three most prevalent included 68% of the women and 66% of the men, respectively. The top cluster included coincident diseases in both men and women: Metabolic disorders, Hypertensive diseases, Mental and behavioural disorders due to psychoactive substance use, Other dorsopathies, and Other soft tissue disorders.
Conclusion
Non-hierarchical cluster analysis identified multimorbidity patterns consistent with clinical practice, identifying phenotypic subgroups of patients.
Electronic supplementary material
The online version of this article (10.1186/s12875-018-0790-x) contains supplementary material, which is available to authorized users.
Keywords: Multimorbidity, Cluster analysis, Multiple correspondence analysis, K-means clustering, Primary health care, Electronic health records, Diseases
Background
In the first decade of the twenty-first century, tremendous effort was concentrated on surfacing data about multimorbidity patterns in order to increase the knowledge of how the diseases were clustered [1–3]. In everyday primary care settings, multimorbidity is more the norm than an exception, with a prevalence ranging from 13 to 95% in the global population, depending on the age group included and methodology used [2]. Therefore, establishing these clustered associations could inform Clinical Practice Guidelines (CPG) and guide decision-making in the clinical practice [4].
No consensus has been established about a standard model to determine multimorbidity patterns. Differences between studies have been observed, such as the unit of analysis selected (patients versus diseases), the statistical method for grouping diseases (factor analysis vs. cluster analysis), diseases included (chronic or all), and number of diseases included in the models [1, 5].
To identify the multimorbidity patterns, methods that identify and separate certain population groups from others and study non-random associations between diseases in those sub-groups are needed [3, 6]. There are basically two statistical methods for grouping diseases: factor analysis and cluster analysis. Exploratory factor analysis is based on correlations between diagnoses to identify the patterns; it is used to test hypothesised relationships between observed measures and latent constructs and allows the inclusion of a diagnosis in multiple factors. In contrast, cluster analysis obtains the patterns of multimorbidity based on dissimilarities between diseases; clusters tend to contain diagnoses that are similar to each other (in terms of Euclidean distances) and a diagnosis cannot be included in more than one cluster. Usually, factor analysis is used to study diseases and cluster analysis to study patients [7]. A recent comparison of the two methods concluded that cluster analysis is more useful than factor analysis for in-depth study of multimorbidity patterns [8].
Among cluster analysis methods, there are two main types of techniques: hierarchical (HCA) and non-hierarchical cluster analysis (NHCA) [9]. The first, often considered when choosing a clustering technique in biomedicine, attempts to identify relatively homogeneous groups of cases based on selected characteristics, using an algorithm that either agglomerates or divides entities to form clusters. HCA is organized so that one cluster can be entirely contained within another cluster, but no other kind of overlap between clusters is allowed. However, the technique is not particularly good when it comes to robust identification of patterns in data. The main limitations are that the hierarchical clusters are susceptible to outliers in the data, the final solution depends on the chosen distance measure, and the algorithms are not efficient to analyse large data sets, as they require a large distance matrix. Nevertheless, almost all studies to date have used HCA to analyse multimorbidity patterns [2, 3].
Among the NHCA methods, K-means is the most frequently used. In contrast to HCA, this approach does not involve the construction of groups via iterative division or clustering; instead, patients are assigned to clusters once the number of clusters is specified. The results are less susceptible to outliers in the data, to the influence of choosing a distance measure, or to the inclusion of inappropriate or irrelevant variables. Algorithms that do not require a distance matrix, such as k-means, can analyse extremely large data sets [9–11].
The study of biological heterogeneity requires the identification of subgroups of populations with specific combinations of coexisting diseases. This “multimorbidity patient” approach identifies phenotypes of the subgroups, describes the patterns of diseases within each one, and facilitates the development of more targeted patient management [12].
The purpose of this study was to obtain the multimorbidity patterns in adult patients with multimorbidity attended in primary care in Catalonia (Spain), stratified by sex, using a k-means cluster analysis.
Methods
Design, setting and study population
A cross-sectional study was conducted in Catalonia (Spain), a Mediterranean region with 7,434,632 inhabitants, 81% of which live in urban municipalities (2010 census). The Spanish National Health Service (NHS) provides universal coverage, financed mainly by tax revenue. The Catalan Health Institute (CHI) manages primary health care teams (PHCTs) that serve 5,501,784 patients (274 PHCT), or 74% of the population; the remaining PHCTs are managed by other providers.
The CHI’s Information System for the Development of Primary Care Research (SIDIAP) contains the coded clinical information recorded in electronic health records (EHR) by its 274 PHCTs since 2006. A subset of SIDIAP records meeting the highest quality criteria for clinical data, the SIDIAP-Q, includes 1,833,125 patients attended by the 1365 general practitioners (GPs). SIDIAP Q represents 40% of the SIDIAP population whose data recording scores contain information on the majority of the population of Catalonia, and is highly representative of the whole region in terms of geography, age, sex, and diseases. This study was limited to SIDIAP-Q, as the sample was representative of the population [13].
Prevalence of individual conditions, multimorbidity, and disease patterns varies by age. To obtain a more homogenous sample of multimorbidity, we identified 408,944 patients with multimoribidity aged 45 to 64 years [14] on 31 December 2010 (Additional file 1).
Coding and selection of diseases
Diseases are coded in SIDIAP using International Classification of Diseases version 10 (ICD-10) [15]. For this study, we selected all active diagnoses recorded in EHR as of December 31, 2010, except for R codes (symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified) and Z codes (factors influencing health status and contact with health services). Of the 263 blocks of diagnosis in the ICD-10, excluding the R codes and Z codes yielded 241 blocks. Non-active diagnoses, based on the presence of an end date in the EHR, were excluded. These diagnoses covered a broad list of acute diseases for which the system automatically assigns an end date (e.g., 60 days after the initial diagnosis).
To facilitate information management, the diagnoses were extracted using the 263 blocks (disease categories) in the ICD-10 structure. These are homogeneous categories of very closely related specific diagnoses. For example, Hypertensive diseases include Essential (primary) hypertension, Hypertensive heart disease, Hypertensive renal disease, Hypertensive heart and renal disease, and Secondary hypertension. To obtain consistent and clinically interpretable patterns of association, and to avoid spurious relationships that could bias the results, we considered only diagnoses with greater than 1% prevalence in each sex. All patients with multimorbidity were included.
Multimorbidity definition
Multimorbidity was defined by the presence of two or more ICD-10 diagnoses in the EHR from the 241 blocks selected.
Variables
The unit of measurement was the diagnoses included in the 241 blocks (disease categories) of the ICD-10 structure (values: 1 if present, 0 if absent). Other variables recorded were number of diseases, age (in years), and sex (women, men).
No missing values were handled, as sex and age were recorded for all patients. Wrong sex-specific diagnosis codes and diagnoses with inconsistent dates were excluded during data cleaning. Any record with no disease diagnoses was considered as a disease-free individual.
Statistical analysis
Analyses were stratified by sex. Descriptive statistics were used to summarize overall information. Categorical variables were expressed as frequencies (percentage) and continuous variables as mean (Standard deviation, SD) or median (interquartile range, IQR). Two sample tests of proportions were used to assess sex-based differences between groups Mann Whitney was used to test the non-normally distributed variable of number of blocks of diagnoses by sex.
We identified disease patterns using two steps:
Multiple Correspondence Analysis (MCA): A data analysis technique for nominal categorical data, was used to detect and represent underlying structures in the data set. The method allows representation in a multidimensional space of relationships between a set of dichotomous or categorical variables (in our case, diagnoses) that would otherwise be difficult to observe in contingency tables and show groups of patients with the same characteristics [16]. MCA also allows direct representation of patients as points (coordinates) in geometric space, transforming the original binary data to continuous data (Additional file 2). The MCA analysis was based on the indicator matrix. Optimal number of dimensions extracted and percentages of inertia were determined by the means of scree plot.
K-means clustering: From the geometric space created in MCA, patients were classified into clusters according to proximity criteria by means of the k-means algorithm. The algorithm is composed of the following steps: 1) Place K points into the space represented by the patients that are being clustered. These points represent initial group centroids. 2) Assign each patient to the group that has the closest centroid. 3) When all patients have been assigned, recalculate the positions of the K centroids. Repeat Steps 2 and 3 until the centroids no longer move. This produces a separation of the patients into homogenous groups while maximizing heterogeneity across groups [9]. The optimal number of clusters is the solution with the highest Calinski-Harabasz index value. To assess internal cluster quality, cluster stability of the optimal solution was computed using Jaccard bootstrap values with 100 runs [17]. Highly stable clusters should yield average Jaccard similarities of 0.85 and above [9].
Statistics of multimorbidity patterns
To describe the multimorbidity patterns in patients, frequencies and percentages of diseases in each cluster were calculated. Observed/expected ratios (“O/E-ratios”) were calculated by dividing disease prevalence in the cluster by disease prevalence in the sex group. A disease was considered to be associated with the multimorbidity pattern when O/E-ratio was ≥2 [18]. Exclusivity, defined as the fraction of patients with the disease included in the cluster over the total strata patients with the disease, was also calculated. To describe the relative position of the clusters, centrality defined as the distance of the cluster centroid to the origin was calculated. Descriptive statistics of age and the median number of diagnoses for each cluster were also obtained. Clinical criteria were used to evaluate the consistency and utility of the final cluster solution. To reduce the size of the tables, only groups of diseases with a prevalence higher than 10% in the cluster were shown.
The analyses were carried out using SPSS for Windows, version 18 (SPSS Inc., Chicago, IL, USA) and R version 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria).
Results
Out of 523,656 patients aged 45 to 64 years, 408,994 (78.1%) met the multimorbidity criteria. Women had a higher multimorbidity prevalence than men (82.2% vs. 73.9%, p < 0.001). The mean age was 54.2 years (Standard deviation [SD]: 5.8), 53.3% were women, and the mean number of diagnoses per patient was 5.7 (SD: 3.3). The analysis included 217,823 women and 191,171 men with 79 and 73 different diagnoses, respectively (Table 1 and Additional file 3).
Table 1.
Number of diseases for patients 45–64 years old, stratified by sex, Catalonia, 2010*
| Women n (%) 217,823 (82.2) |
Men n (%) 191,171 (73.9) |
|
|---|---|---|
| Number of diagnoses† | ||
| 2 | 26,106 (12.0) | 33,850 (17.7) |
| 3 | 28,243 (13.0) | 33,515 (17.5) |
| 4 | 28,274 (13.0) | 30,356 (15.9) |
| ≥ 5 | 135,200 (62.1) | 93,450 (48.9) |
| Median number of diagnoses (IQR)‡ | 5 (4–8) | 4 (3–7) |
| Number of diagnoses included | 79 | 73 |
Abbreviations: IQR inter-quartile range
*Included in the analysis N = 523,656, people with ≥2 diagnoses; 408,994 (78.1%)
†Two sample test of proportions; all p-values< 0.001
‡Mann-Whitney test; P < 0.001
Data were transformed using MCA (Additional file 2). K-means clustering using Calinski criterion to obtain six clusters was considered the optimal solution for both women and men. Average Jaccard bootstrap values for women and men were 0.98 and 0.90, respectively, showing highly stable solutions. A spatial representation of clusters is shown with a cluster plot for women (Fig. 1a) and men (Fig. 1b).
Fig. 1.
a and b. Patients cluster plot for women (n = 217,823) and men (n = 191,171) aged 45–64 years, analysed with k-means clustering
Six multimorbidity patterns were obtained for each sex. The three most prevalent multimorbidity patterns included 68.4% of women patients (Table 2) and 65.6% of men patients (Table 3). The number of diseases included in each pattern varied by sex; women had a higher number of diseases than men, although there was a high coincidence (matching) between them in the type of diseases grouped.
Table 2.
Three most prevalent multimorbidity patterns in women (n = 217,823) aged 45–65 years, Catalonia, 2010
| Cluster n (%)a |
Blocks of diagnoses | Prevalence in cluster (%)b | Prevalence in women (%)c | O/E ratiod | Exclusivity (%) | Centrality | Mean Age | Median number of diagnoses |
|---|---|---|---|---|---|---|---|---|
| 1 | E70-E90:Metabolic disorders | 25.9 | 35.4 | 0.73 | 29.8 | 0.8 | 53.0 | 3 |
| 88,657 (40.7) | M50-M54:Other dorsopathies | 23.6 | 35.8 | 0.66 | 26.9 | |||
| F10-F19:Mental and behavioural disorders due to psychoactive substance use | 21.1 | 18.6 | 1.13 | 46.1 | ||||
| F40-F48:Neurotic. stress-related and somatoform disorders | 20.0 | 27.3 | 0.73 | 29.9 | ||||
| N80-N98:Noninflammatory disorders of female genital tract | 17.6 | 24.2 | 0.73 | 29.6 | ||||
| I10-I15:Hypertensive diseases | 15.6 | 25.6 | 0.61 | 24.9 | ||||
| M70-M79:Other soft tissue disorders | 13.9 | 27.0 | 0.52 | 21.0 | ||||
| E00-E07:Disorders of thyroid gland | 11.8 | 14.9 | 0.79 | 32.3 | ||||
| D10-D36:Benign neoplasms | 10.4 | 16.2 | 0.65 | 26.3 | ||||
| 2 | M50-M54:Other dorsopathies | 55.4 | 35.8 | 1.55 | 23.0 | 1.6 | 57.4 | 7 |
| 32,249 (14.8) | E70-E90:Metabolic disorders | 53.6 | 35.4 | 1.52 | 22.4 | |||
| M15-M19:Arthrosis | 48.2 | 15.7 | 3.08 | 45.6 | ||||
| M70-M79:Other soft tissue disorders | 47.5 | 27.0 | 1.76 | 26.1 | ||||
| M80-M85:Disorders of bone density and structure | 38.7 | 11.3 | 3.41 | 50.5 | ||||
| M20-M25:Other joint disorders | 33.0 | 18.6 | 1.78 | 26.3 | ||||
| F40-F48:Neurotic. stress-related and somatoform disorders | 30.1 | 27.3 | 1.10 | 16.3 | ||||
| I10-I15:Hypertensive diseases | 29.3 | 25.6 | 1.14 | 16.9 | ||||
| I80-I89:Diseases of veins. Lymphatic vessels and lymph nodes. Not elsewhere classified | 29.2 | 18.3 | 1.60 | 23.7 | ||||
| F30-F39:Mood [affective] disorders | 20.8 | 14.6 | 1.43 | 21.1 | ||||
| N80-N98:Noninflammatory disorders of female genital tract | 20.5 | 24.2 | 0.85 | 12.5 | ||||
| E65-E68:Obesity and other hyperalimentation | 20.5 | 19.0 | 1.08 | 16.0 | ||||
| G50-G59:Nerve. nerve root and plexus disorders | 20.0 | 8.5 | 2.34 | 34.7 | ||||
| M45-M49:Spondylopathies | 19.7 | 4.3 | 4.56 | 67.4 | ||||
| E00-E07:Disorders of thyroid gland | 17.8 | 14.9 | 1.20 | 17.7 | ||||
| M40-M43:Deforming dorsopathies | 15.1 | 3.8 | 3.96 | 58.6 | ||||
| D10-D36:Benign neoplasms | 12.4 | 16.2 | 0.77 | 11.4 | ||||
| K20-K31:Diseases of oesophagus. Stomach and duodenum | 12.0 | 11.4 | 1.05 | 15.6 | ||||
| J30-J39:Other diseases of upper respiratory tract | 11.2 | 9.4 | 1.19 | 17.6 | ||||
| G40-G47:Episodic and paroxysmal disorders | 11.2 | 10.5 | 1.06 | 15.7 | ||||
| J00-J06:Acute upper respiratory infections | 11.1 | 12.6 | 0.88 | 13.0 | ||||
| H90-H95:Other disorders of ear | 10.2 | 6.3 | 1.60 | 23.7 | ||||
| 3 | N80-N98:Noninflammatory disorders of female genital tract | 48.1 | 24.2 | 1.99 | 25.6 | 1.7 | 53.0 | 8 |
| 28,024 (12.9) | M50-M54:Other dorsopathies | 46.9 | 35.8 | 1.31 | 16.9 | |||
| M70-M79:Other soft tissue disorders | 38.8 | 27.0 | 1.44 | 18.5 | ||||
| M20-M25:Other joint disorders | 33.6 | 18.6 | 1.81 | 23.3 | ||||
| D10-D36:Benign neoplasms | 32.8 | 16.2 | 2.03 | 26.1 | ||||
| I80-I89:Diseases of veins. Lymphatic vessels and lymph nodes. Not elsewhere classified | 29.3 | 18.3 | 1.60 | 20.6 | ||||
| L20-L30:Dermatitis and eczema | 28.4 | 9.3 | 3.05 | 39.2 | ||||
| E70-E90:Metabolic disorders | 27.7 | 35.4 | 0.78 | 10.1 | ||||
| F40-F48:Neurotic. stress-related and somatoform disorders | 26.3 | 27.3 | 0.96 | 12.4 | ||||
| K00-K14:Diseases of oral cavity. Salivary glands and jaws | 23.3 | 12.1 | 1.93 | 24.9 | ||||
| B35-B49:Mycoses | 19.8 | 5.7 | 3.46 | 44.5 | ||||
| D50-D53:Nutritional anaemias | 19.7 | 8.3 | 2.38 | 30.6 | ||||
| N60-N64:Disorders of breast | 19.2 | 7.5 | 2.56 | 32.9 | ||||
| J00-J06:Acute upper respiratory infections | 16.9 | 12.6 | 1.34 | 17.2 | ||||
| H53-H54:Visual disturbances and blindness | 16.8 | 4.4 | 3.84 | 49.4 | ||||
| E00-E07:Disorders of thyroid gland | 16.7 | 14.9 | 1.13 | 14.5 | ||||
| L60-L75:Disorders of skin appendages | 16.7 | 4.8 | 3.51 | 45.2 | ||||
| I10-I15:Hypertensive diseases | 15.9 | 25.6 | 0.62 | 8.0 | ||||
| E65-E68:Obesity and other hyperalimentation | 15.4 | 19.0 | 0.81 | 10.4 | ||||
| J30-J39:Other diseases of upper respiratory tract | 15.2 | 9.4 | 1.61 | 20.8 | ||||
| G40-G47:Episodic and paroxysmal disorders | 14.0 | 10.5 | 1.33 | 17.1 | ||||
| B00-B09:Viral infections characterized by skin and mucous membrane lesions | 13.9 | 4.3 | 3.21 | 41.2 | ||||
| H90-H95:Other disorders of ear | 12.9 | 6.3 | 2.03 | 26.2 | ||||
| H49-H52:Disorders of ocular muscles. Binocular movement. Accommodation and refraction | 12.9 | 3.5 | 3.64 | 46.8 | ||||
| L80-L99:Other disorders of the skin and subcutaneous tissue | 12.8 | 3.3 | 3.83 | 49.3 | ||||
| H10-H13:Disorders of conjunctiva | 12.2 | 3.8 | 3.21 | 41.3 | ||||
| F30-F39:Mood [affective] disorders | 11.7 | 14.6 | 0.80 | 10.3 | ||||
| K55-K63:Other diseases of intestines | 11.3 | 8.6 | 1.32 | 17.0 | ||||
| M15-M19:Arthrosis | 11.1 | 15.7 | 0.71 | 9.2 | ||||
| K20-K31:Diseases of oesophagus. Stomach and duodenum | 10.3 | 11.4 | 0.91 | 11.7 |
aIndividuals (% of total women) / bIndividuals as % of cluster / cIndividuals as % of total women)
dObserved / Expected Ratio. Values ≥2 in bold
Table 3.
Three most prevalent multimorbidity patterns in men (n = 191,171) aged 45–65 years, Catalonia, 2010
| Cluster n (%)a |
Blocks of diagnoses | Prevalence in cluster (%)b | Prevalence in men (%)c | O/E ratiod | Exclusivity (%) | Centrality | Mean Age | Median number of diagnoses |
|---|---|---|---|---|---|---|---|---|
| 1 | E70-E90:Metabolic disorders | 38.4 | 42.2 | 0.91 | 35.3 | 0.8 | 53.3 | 3 |
| 73,979 (38.7) | I10-I15:Hypertensive diseases | 28.1 | 32.5 | 0.86 | 33.4 | |||
| F10-F19:Mental and behavioural disorders due to psychoactive substance use | 25.4 | 33.6 | 0.76 | 29.2 | ||||
| M50-M54:Other dorsopathies | 20.8 | 27.8 | 0.75 | 28.9 | ||||
| M70-M79:Other soft tissue disorders | 10.7 | 16.9 | 0.63 | 24.6 | ||||
| E65-E68:Obesity and other hyperalimentation | 10.6 | 14.6 | 0.73 | 28.2 | ||||
| 2 | F10-F19:Mental and behavioural disorders due to psychoactive substance use | 77.3 | 33.6 | 2.30 | 34.9 | 1.5 | 52.6 | 4 |
| 28,951 (15.1) | E70-E90:Metabolic disorders | 26.4 | 42.2 | 0.63 | 9.5 | |||
| F40-F48:Neurotic. stress-related and somatoform disorders | 25.1 | 13.5 | 1.86 | 28.1 | ||||
| M50-M54:Other dorsopathies | 23.7 | 27.8 | 0.85 | 12.9 | ||||
| K00-K14:Diseases of oral cavity. Salivary glands and jaws | 23.2 | 12.0 | 1.93 | 29.2 | ||||
| J40-J47:Chronic lower respiratory diseases | 19.4 | 9.3 | 2.09 | 31.6 | ||||
| F30-F39:Mood [affective] disorders | 17.0 | 6.3 | 2.72 | 41.2 | ||||
| B15-B19:Viral hepatitis | 16.6 | 3.2 | 5.13 | 77.6 | ||||
| I10-I15:Hypertensive diseases | 14.2 | 32.5 | 0.44 | 6.6 | ||||
| K70-K77:Diseases of liver | 12.5 | 5.2 | 2.38 | 36.1 | ||||
| K20-K31:Diseases of oesophagus. Stomach and duodenum | 12.3 | 11.5 | 1.06 | 16.1 | ||||
| M70-M79:Other soft tissue disorders | 10.4 | 16.9 | 0.62 | 9.4 | ||||
| 3 | E70-E90:Metabolic disorders | 43.4 | 42.2 | 1.03 | 12.1 | 1.9 | 55.2 | 6 |
| 22,458 (11.8) | K20-K31:Diseases of oesophagus. Stomach and duodenum | 40.0 | 11.5 | 3.47 | 40.7 | |||
| K40-K46:Hernia | 31.3 | 8.8 | 3.57 | 41.9 | ||||
| N40-N51:Diseases of male genital organs | 30.9 | 12.1 | 2.54 | 29.9 | ||||
| I10-I15:Hypertensive diseases | 30.3 | 32.5 | 0.93 | 10.9 | ||||
| M50-M54:Other dorsopathies | 29.6 | 27.8 | 1.06 | 12.5 | ||||
| I80-I89:Diseases of veins. Lymphatic vessels and lymph nodes. Not elsewhere classified | 29.6 | 10.0 | 2.95 | 34.7 | ||||
| K55-K63:Other diseases of intestines | 28.2 | 6.4 | 4.39 | 51.6 | ||||
| D10-D36:Benign neoplasms | 21.1 | 8.6 | 2.46 | 28.9 | ||||
| F10-F19:Mental and behavioural disorders due to psychoactive substance use | 20.8 | 33.6 | 0.62 | 7.3 | ||||
| F40-F48:Neurotic. stress-related and somatoform disorders | 19.7 | 13.5 | 1.46 | 17.2 | ||||
| J30-J39:Other diseases of upper respiratory tract | 16.1 | 8.0 | 2.01 | 23.6 | ||||
| M70-M79:Other soft tissue disorders | 15.6 | 16.9 | 0.92 | 10.9 | ||||
| G40-G47:Episodic and paroxysmal disorders | 13.1 | 7.4 | 1.77 | 20.8 | ||||
| N20-N23:Urolithiasis | 13.0 | 4.3 | 3.00 | 35.3 | ||||
| J40-J47:Chronic lower respiratory diseases | 12.0 | 9.3 | 1.29 | 15.1 | ||||
| H90-H95:Other disorders of ear | 10.8 | 7.7 | 1.40 | 16.5 |
aIndividuals (% of total men) / bIndividuals as % of the cluster /cIndividuals as % of total men
dObserved / Expected Ratio. Values ≥2 in bold
The clusters were sorted in descending order by number of individuals included. The first cluster included about 40% of the population (40.7% of women and 38.7% of men) and no O/E ratio higher than 2 was observed in these first clusters. In these first clusters, the highest exclusivity value was 46.1% for Mental and behavioural disorders due to psychoactive substance use (tobacco) in women and 35.3% for Metabolic disorders in men.
The most prevalent cluster included coincident diseases in both men and women: Metabolic disorders, Hypertensive diseases, Mental and behavioural disorders due to psychoactive substance use, Other dorsopathies and Other soft tissue disorders (Tables 2 and 3).
Four other patterns were almost coincident between the sexes: 1) Cluster 4 (women) and cluster 3 (men), composed mostly of diseases of the digestive and musculoskeletal system; 2) Cluster 2 (women) and Cluster 4 (men), connective tissue diseases; 3) Cluster 5 was composed of a cardiometabolic pattern (obesity, hypertension and diabetes) in both groups; and 4) Cluster 6, infectious and injurious diseases (see Tables 2 and 3). O/E ratios varied for each cluster, peaking at 8.99 for Other viral diseases and 8.24 for Other acute lower respiratory infections in cluster 6 (women) (Tables 2 and 3).
In both sexes, the most prevalent multimorbidity pattern in the oldest patients (Tables 2 and 3) were musculoskeletal system and connective tissue diseases in women (mean age: 57.4) and cardiometabolic pattern (obesity, hypertension, and diabetes) in men (mean age: 57.1).
Multimorbidity patterns considering only blocks of diagnoses with O/E ratio ≥ 2, ordered by exclusivity in women and men, showed that the highest exclusivity in women was observed in Cluster 6: 83.9% of the people who had a diagnosis of Other viral diseases are included in this cluster. They were followed by Cluster 5, which 77.0% of people with Diabetes mellitus belonged to. In men, 83.7% of people with Disorders of choroid and retina belongs to Cluster 5, and 77.6%, which includes Viral hepatitis, in Cluster 2 (Additional file 4).
Discussion
Non-hierarchical cluster analysis yielded an informative categorization of patients, generating reasonable multimorbity patterns from a clinical, practical perspective, and identified phenotypes for sub-groups of patients. Metabolic-circulatory-tobacco use-musculoskeletal pattern is the most common multimorbidity pattern identified by NHCA in both sexes. This pattern would be classified as nonspecific because it had the lowest centrality value (0.8 for both sexes). It is the most common in the population with multimorbidity aged 45–65 years. This pattern seems to be consistent with other studies which obtained similar associations of diseases with other methods of analysis [2, 3].
Other data of interest are the higher exclusivity values obtained in some clusters. For example, 77% of women who suffered diabetes mellitus have other associated diseases, such as forms of heart disease, obesity, and hypertension. These results are similar to the report from Hughes et al. that 71% of people with diabetes had multimorbidity [19]. Other coexisting diseases in the 84% of men who had disorders of choroid and retina (ischemic heart diseases, diseases of arteries, arterioles and capillaries, diabetes, other forms of heart disease, obesity, and hypertension) reflect a broad affectation of the vascular tree. Another remarkable observation in some patterns was the clustering of diseases of the same system or the presence of diseases, reflecting a complication. For example, one multimorbidity pattern consisted of seven diseases, of which five were diseases of the musculoskeletal system and connective tissue (Cluster 2, women). Another well-known example is the complications of diabetes mellitus such as disorders of choroid and retina (diabetic retinopathy) and renal failure (Cluster 5, men).
These results can be translated into clinical practice. When a disease is first diagnosed, we can suspect other associated diseases. Clinical practice guidelines could orient their recommendations toward these sub-groups (for example: arthritis, anxiety and depression). On the other hand, some results could be difficult to interpret in the context of current knowledge. Some patterns obtained included many diseases with no apparent connection between them.
In general, it is difficult to compare our results with the findings of other studies because of variations in methods, data sources and structures, populations, and diseases studied. However, there are some similarities between the current study and others. The first pattern is similar to the cardio-metabolic pattern reported by Prados et al. in adults aged 45 to 64 years (hypertension, diabetes, obesity, and lipid metabolism disorders) with an exploratory factor analysis [6]. In participants older than 50 years, another study found a cardiorespiratory factor (angina, asthma, and chronic lung disease) quite similar to our Cluster 5 in men and a mental-arthritis factor (arthritis, anxiety and depression) similar to our Cluster 2 in women [20].
The major strength of this study is the large, high-quality population database of primary care records that have been shown to be representative of a much larger population [13]. The analysis was stratified by sex and a patient-level perspective was used with NHCA. Admittedly, this analysis of almost all potential diagnoses may have added a complexity that will hinder interpretation of findings and comparison with other studies. Another major strength of this study was the operational definition of multimorbidity as the co-occurrence of multiple chronic or acute diseases [21] which allows the inclusion of the full range of diseases observed in any one patient. This is especially relevant because the boundaries between chronic and acute disease are not always clear [22, 23]. The strengths of using K-means cluster analysis is that the results are less susceptible to outliers in the data, the influence of chosen distance measure, or the inclusion of inappropriate or irrelevant variables [10]. The method can also analyse extremely large data sets as in our study, as no distance matrix is required. Some disadvantages of the method are that different solutions for each set of seed points can occur and there is no guarantee of optimal clustering [12]. To minimize this shortcoming, we tested the internal validity of our solution using bootstrap methods, and the results were highly stable (Jaccard> 0.85) [17]. In addition, the method is not efficient when a large number of potential cluster solutions are to be considered [10]; to address this limitation, we computed the optimal number using analytical indexes like Calinski Harabasz [24].
A number of limitations need to be taken into account as well. The use of MCA can produce low percentages of variation on principal axes and make it difficult to choose the number of dimensions to retain. We assumed a 5-dimension solution using the elbow rule in the scree plot to achieve the most accurate solution possible without including too many dimensions in the analysis [16]. In some clusters, an accumulative diagnosis belonging to the same chapter could be coded in multiple ways; however, use of the structure of ICD10 3-character codes that group diseases as the unit of analysis, rather than the more specific individual diagnosis, makes this improbable.
Few studies have focused on the MM patterns in patients rather than on diseases [25–27]. This methodology produced results that can be transferred to clinical practice, as they suggested that diseases are not equally associated with all phenotypes and there may be a genetic basis for patterns of multimorbidity.
Multimorbidity can present a problem for health services delivery, affecting patients, health professionals, and managers who are attempting to improve service delivery [28]. Our study offers a new methodological approach to understanding the relationships between specific diseases in individual patients, which is an essential step in improving the care of patients and health systems in organizations. Analysing patient profiles permitted the identification of subgroups of patients with different associated diseases.
This study illustrates the need to pay careful attention to the methods used to support policies and decision-making. The study results have implications for three fundamental areas of action: a) the need to change the orientation of clinical guidelines that focus on a single disease; b) the need to change health policy that is based on a disease rather than on the whole person; and c) the need to change current incentive policies that focus the health professional’s attention on a disease rather than on multimorbidity, which includes not only diseases but also drug interactions, polypharmacy and the process of patient-health professional interactions.
Future studies on the current topic are therefore recommended, with a special focus on three major issues. First, the genetic typing of these multimorbidity patterns will identify genetic confluence in these patterns. Second, the delimitation of environment factors (alimentation, physical exercise, toxicity, etc.) associated with these patterns. Third, longitudinal studies should be done to establish the order of disease onset. Finally, the influence of polypharmacy, or the use of multiple drugs, could decrease treatment efficacy and cause unexpected adverse events or even the development of other diseases [29, 30].
These findings suggest that multimorbidity patterns obtained using non-hierarchical cluster analysis identified clusters more consistent with clinical practice, identifying phenotypes of certain sub-groups of patients.
Conclusion
Non-hierarchical cluster analysis identified multimorbidity patterns consistent with clinical practice, identifying phenotypic subgroups of patients.
Additional files
Study Flow Chart, Catalonia, 2010. (DOCX 35 kb)
Patients factor map for women (right, n = 217,823) and men (left, n = 191,171) aged 45–64 years. (DOCX 1468 kb)
Diagnosis blocks (ICD 10) included in the Multimorbidity patterns in women and men aged 45–65 years, Catalonia, 2010. (DOCX 26 kb)
Multimorbidity patterns considering only blocks of diagnoses with Observed/Expected ratio ≥ 2, ordered by exclusivity in women and men aged 45–65 years, Catalonia, 2010. (DOCX 25 kb)
Acknowledgements
We thank the Catalan Health Institute and especially the SIDIAP Unit, which provided the database for the study. The authors also appreciate the English language review by Elaine Lilly, PhD, and are grateful to Carmen Ibáñez for administrative work.
Funding
The project has been funded by the Instituto de Salud Carlos III of the Ministry of Economy and Competitiveness (Spain) through the Network for Prevention and Health Promotion in Primary Health Care (redIAPP, RD12/0005), by a grant for research projects on health from ISCiii (PI12/00427) and co-financed with European Union ERDF funds). Jose M. Valderas was supported by the National Institute for Health Research Clinician Scientist Award NIHR/CS/010/024. The funders had no role in the study design, collection, analysis and interpretation of data, writing of the manuscript or decision to submit for publication. The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research, or the National Department of Health.
Availability of data and materials
The datasets are not available because researchers have signed an agreement with the Information System for the Development of Research in Primary Care (SIDIAP) concerning confidentiality and security of the dataset that forbids providing data to third parties. This organization is subject to periodic audits to ensure the validity and quality of the data.
Abbreviations
- CHI
Catalan Health Institute
- CPG
Clinical Practice Guidelines
- EHR
Electronic Health Records
- HCA
Hierarchical Clustering Analysis
- ICD-10
International Classification of Diseases version 10
- IQR
Interquartile Range
- MCA
Multiple Correspondence Analysis
- NHCA
Non-hierarchical cluster analysis
- NHS
National Health Service
- O/E-ratios
Observed/expected ratios
- PHCTs
Primary Health Care Teams
- SD
Standard Deviation
- SIDIAP
Information System for the Development of Research in Primary Care
Authors’ contributions
All authors contributed to the design of the study, revised the article, and approved the final version. CV and QFB obtained the funding. ARL, CV, QFB and MGC contributed to the analysis and interpretation of data. CV, ARL, QFB wrote the first draft, and the rest of authors (MGC, MPV, EPR, and JMV) contributed ideas, interpreted the findings and reviewed rough drafts of the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The protocol of the study was approved by the Committee on the Ethics of Clinical Research, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol) (Protocol No: P12/28). All data provided by the Information System for the Development of Primary Care Research (SIDIAP) and are always anonymized and confidential. Thus, informed consent does not need to be obtained from the participants. SIDIAP is subject to Spanish law LO 15/ 1999 13 December, Protection of personal data privacy (Protección de Datos de Carácter Personal) and international law.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Footnotes
Electronic supplementary material
The online version of this article (10.1186/s12875-018-0790-x) contains supplementary material, which is available to authorized users.
Contributor Information
Concepción Violán, Phone: 0034 93 482 41 24, Email: cviolan@idiapjgol.org, http://www.idiapjgol.org.
Albert Roso-Llorach, Email: aroso@idiapjgol.org.
Quintí Foguet-Boreu, Email: 42292qfb@comb.cat.
Marina Guisado-Clavero, Email: marina.guisado@gmail.com.
Mariona Pons-Vigués, Email: mponsv@idiapjgol.org.
Enriqueta Pujol-Ribera, Email: epujol@idiapjgol.org.
Jose M. Valderas, Email: J.M.Valderas@exeter.ac.uk
References
- 1.Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10(4):430–439. doi: 10.1016/j.arr.2011.03.003. [DOI] [PubMed] [Google Scholar]
- 2.Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9:e102149. doi: 10.1371/journal.pone.0102149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Prados-Torres A, Calderon-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67:254–266. doi: 10.1016/j.jclinepi.2013.09.021. [DOI] [PubMed] [Google Scholar]
- 4.Weiss CO, Varadhan R, Puhan MA, Vickers A, Bandeen-Roche K, Boyd CM, et al. Multimorbidity and evidence generation. J Gen Intern Med. 2014;29(4):653–660. doi: 10.1007/s11606-013-2660-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Holzer BM, Siebenhuener K, Bopp M, Minder CE. Evidence-based design recommendations for prevalence studies on multimorbidity: improving comparability of estimates. Popul Health Metr. 2017;15(1):9. doi: 10.1186/s12963-017-0126-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, Gimeno-Feliu LA, González-Rubio F, Poncel-Falcó A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One. 2012;7(2):e32190. doi: 10.1371/journal.pone.0032190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Haregu T, Oldenburg B, Setswe G, Elliott J. Perspectives, constructs and methods in the measurement of multimorbidity and comorbidity: a critical review. Internet J Epidemiol. 2012;10(2):1–9. [Google Scholar]
- 8.Roso-Llorach A, Violán C, Foguet-Boreu Q, Rodriguez-Blanco T, Pons-Vigués M, Pujol-Ribera E, et al. Comparative analysis of methods for identifying multimorbidity patterns: a study of “real-world” data. BMJ Open. 2018;8(3):e018986. doi: 10.1136/bmjopen-2017-018986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Everitt BS, Landau S, Leese M, Stahl D. Cluster analysis. 5. Chichester: John Wiley & Sons,Ltd; 2011. [Google Scholar]
- 10.Liao M, Li Y, Kianifard F, Obi E, Arcona S. Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis. BMC Nephrol. 2016;17:25. doi: 10.1186/s12882-016-0238-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ilmarinen P, Tuomisto LE, Niemelä O, Tommola M, Haanpää J, Kankaanranta H. Cluster Analysis on Longitudinal Data of Patients With Adult-Onset Asthma. J Allergy Clin Immunol Pract. 2017;S2213–2198(17):30048-X. doi: 10.1016/j.jaip.2017.01.027. [DOI] [PubMed] [Google Scholar]
- 12.Fabbri E, Zoli M, Gonzalez-Freire M, Salive ME, Studenski SA, Ferrucci L. Aging and multimorbidity: new tasks, priorities, and Frontiers for integrated Gerontological and clinical research. J Am Med Dir Assoc. 2015;16(8):640–647. doi: 10.1016/j.jamda.2015.03.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.García-Gil MM, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R, et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP) Inform Prim Care. 2011;19(3):135–145. doi: 10.14236/jhi.v19i3.806. [DOI] [PubMed] [Google Scholar]
- 14.Violán C, Foguet-Boreu Q, Roso-Llorach A, Rodriguez-Blanco T, Pons-Vigués M, Pujol-Ribera E, et al. Burden of multimorbidity, socioeconomic status and use of health services across stages of life in urban areas: a cross-sectional study. BMC Public Health. 2014;14:1–13. doi: 10.1186/1471-2458-14-530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.World Health Organization: ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Version for 2010. http://apps.who.int/classifications/apps/icd/icd10online/ . Accessed 20 Feb 2016.
- 16.Sourial N, Wolfson C, Zhu B, Quail J, Fletcher J, Karunananthan S, et al. Correspondence analysis is a useful tool to uncover the relationships among categorical variables. J Clin Epidemiol. 2010;63(6):638–646. doi: 10.1016/j.jclinepi.2009.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hennig C. Cluster-wise assessment of cluster stability. Computational Statistics & Data Analysis. 2007;52:258–271. doi: 10.1016/j.csda.2006.11.025. [DOI] [Google Scholar]
- 18.Schäfer I, Kaduszkiewicz H, Wagner HO, Schön G, Scherer M, van den Bussche H. Reducing complexity: a visualisation of multimorbidity by combining disease clusters and triads. BMC Public Health. 2014;14:1285. doi: 10.1186/1471-2458-14-1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hughes LD, McMurdo ME, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42(1):62–69. doi: 10.1093/ageing/afs100. [DOI] [PubMed] [Google Scholar]
- 20.Garin N, Olaya B, Perales J, Moneta MV, Miret M, Ayuso-Mateos JL, et al. Multimorbidity patterns in a national representative sample of the Spanish adult population. PLoS One. 2014;9(1):e84794. doi: 10.1371/journal.pone.0084794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Van den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multi- morbidity: what’s in a name? A review of literature. Eur J Gen Pract. 1996;2:65–70. doi: 10.3109/13814789609162146. [DOI] [Google Scholar]
- 22.O'Halloran J, Miller GC, Britt H. Defining chronic conditions for primary care with ICPC-2. Fam Pract. 2004;21(4):381–386. doi: 10.1093/fampra/cmh407. [DOI] [PubMed] [Google Scholar]
- 23.Soler JK, Okkes I, Oskam S, Van Boven K, Zivotic P, Jevtic M, et al. Revisiting the concept of 'chronic disease' from the perspective of the episode of care model. Does the ratio of incidence to prevalence rate help us to define a problem as chronic? Inform Prim Care. 2012;20(1):13–23. doi: 10.14236/jhi.v20i1.44. [DOI] [PubMed] [Google Scholar]
- 24.Calinski RB, Harabasz JA. Dendrite method for cluster analysis. Comm Stat. 1974;3:1–27. [Google Scholar]
- 25.Guisado-Clavero M, Roso-Llorach A, López-Jimenez T, Pons-Vigués M, Foguet-Boreu Q, Muñoz MA, Violán C. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis. BMC Geriatr. 2018;18(1):16. doi: 10.1186/s12877-018-0705-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Newcomer SR, Steiner JF, Bayliss EA. Identifying subgroups of complex patients with cluster analysis. Am J Manag Care. 2011;17:e324e32. [PubMed] [Google Scholar]
- 27.Goldstein G, Luther JF, Jacoby AM, Haas GL, Gordon AJ. A taxonomy of medical comorbidity for veterans who are homeless. J Health Care Poor Underserved. 2008;19:991e1005. doi: 10.1353/hpu.0.0040. [DOI] [PubMed] [Google Scholar]
- 28.McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy. 2016;9:143–156. doi: 10.2147/RMHP.S97248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Marengoni A, Onder G. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. Br Med J. 2015;350:h1059. doi: 10.1136/bmj.h1059. [DOI] [PubMed] [Google Scholar]
- 30.Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. doi: 10.1517/14740338.2013.827660. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Study Flow Chart, Catalonia, 2010. (DOCX 35 kb)
Patients factor map for women (right, n = 217,823) and men (left, n = 191,171) aged 45–64 years. (DOCX 1468 kb)
Diagnosis blocks (ICD 10) included in the Multimorbidity patterns in women and men aged 45–65 years, Catalonia, 2010. (DOCX 26 kb)
Multimorbidity patterns considering only blocks of diagnoses with Observed/Expected ratio ≥ 2, ordered by exclusivity in women and men aged 45–65 years, Catalonia, 2010. (DOCX 25 kb)
Data Availability Statement
The datasets are not available because researchers have signed an agreement with the Information System for the Development of Research in Primary Care (SIDIAP) concerning confidentiality and security of the dataset that forbids providing data to third parties. This organization is subject to periodic audits to ensure the validity and quality of the data.